W0UV28 (W0UV28_HUMAN) Homo sapiens (Human)
Angiogenin UniProtKBInterProInteractive Modelling
147 aa; Sequence (Fasta) ;
2 identical sequences: Homo sapiens: P03950; Gorilla gorilla gorilla: Q71MJ0
Available Structures
52 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX |
Heteromer P03950; P13489; | 100 | ||||
| Crystal structure of Human Angiogenin in complex with Fab fragment of its monoclonal antibody mAb 2… |
Heteromer P03950; | 100 | 8×SO4; 6×GOL; | |||
| CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REVEALS THE STRUCTURAL BASIS FOR ITS FUNCTIONAL DIVERGENCE FR… | homo-2-mer | 100 | ||||
| Crystal structure of human angiogenin and RNA duplex | homo-2-mer | 99.19 | 4×GOL; | |||
| R121H - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis | homo-2-mer | 99.17 | 2×CL; | |||
| Structural snapshots and functional analysis of human angiogenin variants associated with Amyotroph… | monomer | 100 | 1×TAR; 1×TLA; | |||
| Crystal Structure of Human Angiogenin Variant Q117G | monomer | 99.19 | 1×CIT; | |||
| CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN | monomer | 100 | 1×CIT; | |||
| CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT H13A. | monomer | 99.19 | ||||
| CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN OF THE MET(-1) FORM | monomer | 100 | 1×CIT; | |||
| CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT K40Q | monomer | 99.19 | 1×CIT; | |||
| Binding of Phosphate and Pyrophosphate ions at the active site of human angiogenin as revealed by X… | monomer | 100 | 1×PO4; | |||
| Human angiogenin ALS variant H114R | monomer | 99.19 | 1×GOL; 1×BO4; | |||
| Crystal Structure of Human Angiogenin Variant D116H | monomer | 99.19 | ||||
| 3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN DETERMINED BY 1H, 15N NMR SPECTROSCOPY, 30 STRUCTURES | monomer | 100 | ||||
| Human angiogenin ALS variant F100I | monomer | 99.18 | 1×TAR; 1×TLA; 1×PEG; | |||
| X-ray structure of the adduct formed upon reaction of cisplatin with human angiogenin after 5 days … | monomer | 100 | 1×GOL; 1×NH3; 1×PT; 1×TAR; | |||
| Binding of Phosphate and Pyrophosphate ions at the active site of human Angiogenin as revealed by X… | monomer | 100 | 1×POP; | |||
| Crystal structure of human Angiogenin at 1.35 Angstroms resolution | monomer | 100 | ||||
| Human angiogenin PD variant R95Q | monomer | 99.17 | 4×SO4; 3×PEG; 1×PGE; | |||
| Human angiogenin PD/ALS variant R121C | monomer | 99.17 | 1×TLA; 1×GSH; | |||
| Human Angiogenin mutant-S28A | monomer | 99.17 | ||||
| X-ray structure of the adduct formed upon reaction of oxaliplatin with human angiogenin | monomer | 100 | 3×PT; 1×TAR; | |||
| X-ray structure of the adduct formed upon reaction of cisplatin with human angiogenin after 1 month… | monomer | 100 | 1×NH3; 1×PT; | |||
| Binding of Phosphate and Pyrophosphate ions at the active site of human Angiogenin as revealed by X… | monomer | 99.17 | 1×CIT; 1×PO4; | |||
| I46V - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis | monomer | 98.35 | 1×TAR; | |||
| CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T80A | monomer | 99.17 | 1×CIT; | |||
| Human Angiogenin in complex with sulphate anions at an acidic solution | monomer | 100 | 6×SO4; | |||
| S28N - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis | monomer | 99.17 | 1×TAR; | |||
| Human Angiogenin mutant-S28AT36AS37A | monomer | 97.5 | ||||
| Human angiogenin PD variant Q77P | monomer | 99.17 | 2×SO4; 1×PGE; 2×EDO; 1×BTB; | |||
| Crystal Structure of Human Angiogenin Variant des(121-123) | monomer | 100 | 1×CIT; | |||
| Human angiogenin ALS variant T80S | monomer | 99.17 | 4×SO4; | |||
| Human Angiogenin in complex with sulphate anions at a basic solution | monomer | 100 | 4×SO4; 1×GOL; | |||
| Human angiogenin ALS variant V103I | monomer | 99.17 | 1×TAR; | |||
| Human angiogenin PD variant K60E | monomer | 99.17 | 1×TLA; | |||
| V113I - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis | monomer | 99.17 | 1×TLA; | |||
| K54E - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis | monomer | 99.17 | ||||
| Human angiogenin ALS variant K40R | monomer | 99.17 | 1×TAR; 1×PEG; | |||
| K17I - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis | monomer | 99.17 | 1×TLA; | |||
| K17E - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis | monomer | 99.17 | 3×SO4; 1×EDO; | |||
| Human angiogenin PD variant K54R | monomer | 99.17 | 1×TAR; 1×PEG; | |||
| R31K - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis | monomer | 99.17 | 1×TLA; | |||
| ARH-II, AN ANGIOGENIN/RNASE A CHIMERA | monomer | 100 | 1×CIT; | |||
| Human Angiogenin quardruple mutant-S28AT36AS37AS87A | monomer | 96.67 | 1×CIT; | |||
| Crystal Structure of Human Angiogenin with an Engineered Loop Exhibits Conformational Flexibility a… | monomer | 95.12 | ||||
| P112L - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis | monomer | 99.16 | 1×TLA; | |||
| Q12L - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis | monomer | 99.16 | ||||
| Human angiogenin PD variant H13R | monomer | 99.15 | 1×TAR; | |||
| Crystal structure of human angiogenin double variant I119A/F120A | monomer | 98.31 | ||||
| K40I - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis | monomer | 99.15 | ||||
| CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T44D | monomer | 99.13 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1hby.1.A | monomer | 0.88 | 100.00 | |||